Head and Neck Cancers

Encouraging findings for PD-1 inhibitor–based immunotherapies for the treatment of patients with metastatic head and neck cancer are emerging from clinical studies.

Individuals with detectable human papillomavirus (HPV)-16 in their mouthwash samples were 22 times more likely to develop oropharyngeal cancer (OPC) than those without the type of virus, according to findings of a new study.

Results from clinical trials presented at the 2016 Gastrointestinal Cancers Symposium signal a role for the immunotherapy nivolumab (Opdivo) in the treatment of GI malignancies.

The incidence of oropharyngeal cancers is growing-now surpassing cervical cancer-and the increase is expected to continue over the next 30 years, particularly for men currently aged ≤40 years.

Patients who have human papillomavirus 16 DNA in their saliva following treatment of their oropharyngeal cancer are more likely to have their cancer recur, and a simple mouth rinse can be used to detect it.

Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the benefits of treating oral mucositis with low-level laser therapy.

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.

Radiotherapy is equally as effective in the palliation of dysphagia (difficulty swallowing) as chemoradiotherapy for patients with advanced esophageal cancer

For patients receiving treatment for oral and head and neck cancer, maintaining adequate nutrition is an ongoing challenge.

Doxepin rinse may prove to be a viable option for the relief of pain associated with oral mucositis in patients with head and neck cancers

Head and neck cancer patients who participated in a swallow preservation protocol (SPP) were less likely to suffer from the detrimental effects associated with dysphagia, a common complication associated with radiation therapy (RT) and chemoradiation therapy (CRT).

Found to be helpful for patients with head and neck cancer.

Oncology nurses can lead the way in efforts to protect the next generation from this type of cancer if they know the facts about HPV vaccination for both girls and boys

More is now known about the types of HPV that increase risk.

The incidence of cervical cancer, an HPV-associated cancer, declined slightly; however, incidence rates increased for oropharyngeal and anal cancer, which also are considered HPV-associated cancers.

Patients (and even clinicians) often don't know which facilities are considered leaders in the treatment of various types of cancer, and a bit of detective work is generally required.

Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative head and neck cancers.

Singer and songwriter Charlie Lustman has become an inspirational voice for the over 12 million cancer survivors living in the United States

The Emperor of All Maladies bills itself as a "biography of cancer," and while author Siddhartha Mukherjee cannot tell us precisely when cancer opened its eyes in this world...

The John Theurer Cancer Center (JTCC) at Hackensack University Medical Center in New Jersey, one of the largest cancer centers in the United States

Useful Online Resources and Clinical Trials for Oral Cancer